Streetbeat News

Stock Prices

MRMD

MariMed (OTC:MRMD) is scheduled to release its quarterly earnings report on March 6, 2024, with analysts expecting an EPS of $0.00. The company's past earnings performance shows mixed results, with a slight miss last quarter leading to a 0.38% drop in share price. Over the last year, MariMed's shares have declined by 45.74%, indicating a bearish outlook among long-term shareholders. Investors will be keenly watching for not only the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 7:03 pm

SDIG

Stronghold Digital Mining (NASDAQ:SDIG) is scheduled to release its quarterly earnings report on March 6, 2024, with analysts expecting an EPS of $-0.98. The company's past earnings performance shows a mix of misses and beats against estimates, with varying impacts on its stock price. Shares are currently trading at $4.87, down 10.79% over the last year. Investors will be keenly watching for both the earnings outcome and the company's future guidance.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 7:03 pm

NSPR

InspireMD (NASDAQ:NSPR) is scheduled to release its quarterly earnings report on March 6, 2024, with an estimated EPS of $-0.19. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historical data shows mixed reactions to past earnings, with the stock price fluctuating based on actual EPS versus estimates. Shares have risen 126.76% over the last 52 weeks, indicating a positive outlook among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 7:02 pm

KMDA

Kamada (NASDAQ:KMDA) is scheduled to release its quarterly earnings report on March 6, 2024, with analysts predicting an EPS of $0.05. The company's past performance shows a history of beating EPS estimates, which has sometimes led to positive stock price movements. Shares of Kamada have increased by 49.61% over the last 52 weeks, indicating a positive trend for long-term shareholders. Investors will be particularly attentive to the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 7:02 pm

OPUSD

Optimism's cryptocurrency (OP) has seen a significant price increase of 13.93% in the last 24 hours, reaching $4.39. This marks a continuation of its positive trend, with a 19.0% gain over the past week from $3.7. The coin's all-time high is $4.55. Trading volume surged by 275.0%, and the circulating supply rose by 5.91% to 1.01 billion, representing 23.43% of its max supply. Optimism's market cap ranks #30 at $4.46 billion.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 7:02 pm

AMPY

Amplify Energy (NYSE:AMPY) is scheduled to release its quarterly earnings report on 2024-03-06, with analysts estimating an EPS of $0.18. The company's past earnings performance shows a mix of misses and beats, with the stock price reacting accordingly. Investors will be keen on not just the earnings beat or miss but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 7:02 pm

TLPH

Talphera (NASDAQ:TLPH) is scheduled to release its quarterly earnings report on March 6, 2024, with an estimated EPS of $-0.20. Investors are hopeful for a beat on this estimate and positive guidance for the next quarter. Despite beating EPS estimates in the past, Talphera's stock has experienced mixed reactions, including a significant drop of 11.34% following the last earnings beat. Shares are currently trading at $1.3, reflecting a 5.98% increase over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 7:02 pm

CYN

Cyngn (NASDAQ:CYN) is scheduled to release its quarterly earnings report on March 6, 2024, with analysts expecting an EPS of $-0.12. Despite past earnings beats, Cyngn's stock has experienced significant drops following earnings announcements. The company's stock performance has been negative over the last year, with a 78.56% decline. Investors will be closely watching for not only the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 7:02 pm

BRCC

BRC (NYSE:BRCC) is scheduled to release its quarterly earnings report on March 6, 2024, with analysts expecting an EPS of $-0.01. Despite past earnings misses, BRC's stock price has shown volatility post-earnings, with a notable 7.62% increase after the last report. The company's stock has declined 34.99% over the past year, indicating bearish sentiment among long-term investors. The upcoming earnings and particularly the guidance provided will be crucial for investor sentiment.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 7:02 pm

ADAP

Adaptimmune Therapeutics (NASDAQ:ADAP) is scheduled to release its quarterly earnings report on March 6, 2024, with analysts expecting an EPS of $-0.10. The company's past earnings performance shows a mixed record of beating and missing EPS estimates, affecting its stock price variably. Shares have risen 19.58% over the last 52 weeks, trading at $1.48 as of March 4. Investors are advised to watch for the earnings outcome and particularly the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 7:01 pm